Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<scp> <i>PCDHGC3</i> </scp> hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas

25 May 2024

Abstract excerpt

Neuroendocrine neoplasms (NENs) encompass tumors arising from neuroendocrine cells in various organs, including the gastrointestinal tract, pancreas, adrenal gland, and paraganglia. Despite advancements, accurately predicting the aggressiveness of gastroenteropancreatic (GEP) NENs based solely on pathological data remains challenging, thereby limiting optimal clinical management. Our previous research unveiled a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Cancer Research Studies
Share to Neuroendocrine Tumor Research Advances
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38795318
DOI: 10.1002/path.6291

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<scp> <i>PCDHGC3</i> </scp> hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomasPMID 38795318Read ↗

Distinct pancreatic and neuronal Lung Carcinoid molecular subtypes revealed by integrative omic analysisSemantic proximity Read ↗

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs)Semantic proximity Read ↗

Epigenetic Modifications as Novel Biomarkers for Diagnosis, Prognosis, and Therapeutic Targeting in Thyroid, Pancreas, and Lung Neuroendocrine TumorsSemantic proximity Read ↗

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumorsSemantic proximity Read ↗

Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?Semantic proximity Read ↗

Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasmsSemantic proximity Read ↗

Genetic and epigenetic drivers of neuroendocrine tumours (NET)Semantic proximity Read ↗

Molecular pathology and genetics of gastrointestinal neuroendocrine tumours.Semantic proximity Read ↗

Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine NeoplasmsSemantic proximity Read ↗

Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms.Semantic proximity Read ↗

Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implicationsSemantic proximity Read ↗

Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.